Kevin Groudan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kevin Groudan has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Kamesh Gupta
Internal Medicine, Baystate Medical Center, Springfield, USA
2 shared publications - Rohit Singhania
Gastroenterology, Baystate Medical Center, Springfield, USA
2 shared publications - Tiago Martins
Division of Gastroenterology, University of Massachusetts Medical School-Baystate, Springfield, MA, USA
2 shared publications - Ahmed Eltanbedawi
Internal Medicine, Baystate Medical Center, Springfield, USA
1 shared publication - Anusha Ganapati Bhat
Internal Medicine, Baystate Medical Center, Springfield, USA
1 shared publication - Audrey Ready
Internal Medicine, Baystate Medical Center, Springfield, USA
1 shared publication
Latest Publications
- Open Access
- 8 February 2023
- Published by Hindawi Limited in Case Reports in Gastrointestinal Medicine
- Vol. 2023, 1-4
Gastric Anisakiasis Masquerading as Gastroesophageal Reflux Disease
Anisakiasis of the gastrointestinal tract is caused by the consumption of raw or undercooked seafood infected with Anisakis larvae. Penetration of Anisakis larvae into the gastrointestinal mucosa leads to severe epigastric pain, nausea, and vomiting, usually within hours of ingestion of the parasite. Suspicion for gastrointestinal Anisakiasis should be raised in patients with a compatible dietary history. Definitive diagnosis can be made by direct visualization of larvae via endoscopic examination. Although symptoms are self-limiting, the removal of larvae by gastroscopy can hasten relief of symptoms. There are a large number of cases of gastric anisakiasis reported from Japan, Korea, and Western Europe, where it is customary to consume raw fish. Cases reported from the United States are less common, and given the nonspecific symptoms of anisakiasis, the diagnosis can be missed. We report a patient who presented with gastroesophageal reflux disease like symptoms that started after ingesting raw fish. He was found by esophagogastroduodenoscopy to have white, filiform worms penetrating into the wall of his stomach, consistent with a diagnosis of gastric anisakiasis.
- 8 February 2023
- Published by Hindawi Limited in Case Reports in Gastrointestinal Medicine
- Vol. 2023, 1-4
Open AccessGastric Anisakiasis Masquerading as Gastroesophageal Reflux Disease
Anisakiasis of the gastrointestinal tract is caused by the consumption of raw or undercooked seafood infected with Anisakis larvae. Penetration of Anisakis larvae into the gastrointestinal mucosa leads to severe epigastric pain, nausea, and vomiting, usually within hours of ingestion of the parasite. Suspicion for gastrointestinal Anisakiasis should be raised in patients with a compatible dietary history. Definitive diagnosis can be made by direct visualization of larvae via endoscopic examination. Although symptoms are self-limiting, the removal of larvae by gastroscopy can hasten relief of symptoms. There are a large number of cases of gastric anisakiasis reported from Japan, Korea, and Western Europe, where it is customary to consume raw fish. Cases reported from the United States are less common, and given the nonspecific symptoms of anisakiasis, the diagnosis can be missed. We report a patient who presented with gastroesophageal reflux disease like symptoms that started after ingesting raw fish. He was found by esophagogastroduodenoscopy to have white, filiform worms penetrating into the wall of his stomach, consistent with a diagnosis of gastric anisakiasis.
- Open Access
- 28 May 2022
- Published by Hindawi Limited in Case Reports in Gastrointestinal Medicine
- Vol. 2022, 1-4
Mucinous Signet-Cell Adenocarcinoma of the Ileum: A Diagnostic Challenge—Case Report and Review of the Literature
Malignancies of the small intestine are rare. Signet-ring cell carcinoma (SRCC) is one of the rarest forms of adenocarcinoma that can arise in the small intestines. We present a case of a patient who originally presented with abdominal pain and radiographic findings suggestive of ileal congestion. The ileal biopsy specimens were nonspecific, and the patient began a trial of corticosteroid treatment for suspected Crohns disease. A repeat colonoscopy yielded biopsies that were positive for malignancy. The patient then underwent an exploratory laparotomy which led to the diagnosis of SRCC. Given their similar presentations and the extreme rarity of this unusual malignancy, it can be difficult to differentiate between new-onset Crohns disease and SRCC. A review of the literature was conducted to provide us with an improved understanding of previously documented cases of SRCC.
- 28 May 2022
- Published by Hindawi Limited in Case Reports in Gastrointestinal Medicine
- Vol. 2022, 1-4
Open AccessMucinous Signet-Cell Adenocarcinoma of the Ileum: A Diagnostic Challenge—Case Report and Review of the Literature
Malignancies of the small intestine are rare. Signet-ring cell carcinoma (SRCC) is one of the rarest forms of adenocarcinoma that can arise in the small intestines. We present a case of a patient who originally presented with abdominal pain and radiographic findings suggestive of ileal congestion. The ileal biopsy specimens were nonspecific, and the patient began a trial of corticosteroid treatment for suspected Crohns disease. A repeat colonoscopy yielded biopsies that were positive for malignancy. The patient then underwent an exploratory laparotomy which led to the diagnosis of SRCC. Given their similar presentations and the extreme rarity of this unusual malignancy, it can be difficult to differentiate between new-onset Crohns disease and SRCC. A review of the literature was conducted to provide us with an improved understanding of previously documented cases of SRCC.
- Open Access
- 27 February 2021
- Published by Springer Nature in Cureus
- Vol. 13 (2)
Pancreatic Pseudocyst Hemorrhage Complicated by an Acute ST-Elevation Myocardial Infarction
ST-segment elevation myocardial infarction is a medical emergency that requires immediate treatment with potent anti-platelet and anti-coagulant therapies and reperfusion by percutaneous coronary intervention. The use of anti-platelet and anti-coagulant therapies can result in hemorrhagic complications, and their use is challenging in a patient with an active gastrointestinal bleed. We report the case of a patient who simultaneously presented with both an ST-segment elevation myocardial infarction and a hemorrhagic pancreatic pseudocyst. There are currently no comprehensive recommendations to guide treatment of these conditions when presenting concomitantly. This case outlines the multi-disciplinary approach taken by our cardiology and gastroenterology teams and highlights the need to develop management algorithms for these two life-threatening conditions.
- 27 February 2021
- Published by Springer Nature in Cureus
- Vol. 13 (2)
Open AccessPancreatic Pseudocyst Hemorrhage Complicated by an Acute ST-Elevation Myocardial Infarction
ST-segment elevation myocardial infarction is a medical emergency that requires immediate treatment with potent anti-platelet and anti-coagulant therapies and reperfusion by percutaneous coronary intervention. The use of anti-platelet and anti-coagulant therapies can result in hemorrhagic complications, and their use is challenging in a patient with an active gastrointestinal bleed. We report the case of a patient who simultaneously presented with both an ST-segment elevation myocardial infarction and a hemorrhagic pancreatic pseudocyst. There are currently no comprehensive recommendations to guide treatment of these conditions when presenting concomitantly. This case outlines the multi-disciplinary approach taken by our cardiology and gastroenterology teams and highlights the need to develop management algorithms for these two life-threatening conditions.
- Open Access
- 11 February 2021
- Published by Springer Nature in Cureus
- Vol. 13 (2)
Abrikossoff Tumor (Granular Cell Tumor) Presenting in the Esophagus
Abrikossoff tumors, also known as granular cell tumors, are rare and often benign soft tissue neoplasms of Schwann cell origin. The vast majority of cases are reported in the skin and subcutaneous tissue. Only 0.001% of Abrikossoff tumors are estimated to occur in the esophagus. We report a rare case of Abrikossoff tumor of the esophagus in a patient who underwent esophagogastroduodenoscopy for abdominal pain and nausea.
- 11 February 2021
- Published by Springer Nature in Cureus
- Vol. 13 (2)
Open AccessAbrikossoff Tumor (Granular Cell Tumor) Presenting in the Esophagus
Abrikossoff tumors, also known as granular cell tumors, are rare and often benign soft tissue neoplasms of Schwann cell origin. The vast majority of cases are reported in the skin and subcutaneous tissue. Only 0.001% of Abrikossoff tumors are estimated to occur in the esophagus. We report a rare case of Abrikossoff tumor of the esophagus in a patient who underwent esophagogastroduodenoscopy for abdominal pain and nausea.
- Open Access
- 31 January 2021
- Published by Springer Nature in Cureus
- Vol. 13 (1)
Neutropenic Enterocolitis Complicating Induction Chemotherapy in an Acute Myeloid Leukemia Patient
Neutropenic enterocolitis is a rare inflammatory condition of the ileocecum. Clinicians should be aware of neutropenic enterocolitis in neutropenic patients with hematologic malignancies undergoing chemotherapy as it portends a poor prognosis if not diagnosed early in its course. We report a patient diagnosed with neutropenic enterocolitis within one week of receiving induction chemotherapy for acute myeloid leukemia.
- 31 January 2021
- Published by Springer Nature in Cureus
- Vol. 13 (1)
Open AccessNeutropenic Enterocolitis Complicating Induction Chemotherapy in an Acute Myeloid Leukemia Patient
Neutropenic enterocolitis is a rare inflammatory condition of the ileocecum. Clinicians should be aware of neutropenic enterocolitis in neutropenic patients with hematologic malignancies undergoing chemotherapy as it portends a poor prognosis if not diagnosed early in its course. We report a patient diagnosed with neutropenic enterocolitis within one week of receiving induction chemotherapy for acute myeloid leukemia.
- Open Access
- 8 January 2021
- Published by Springer Nature in Cureus
- Vol. 13 (1)
Vedolizumab (Entyvio®) for the Treatment of Pyoderma Gangrenosum in a Crohn's Disease Patient
Vedolizumab is a humanized monoclonal integrin blacker with gut selective effects on lymphocyte trafficking. Its efficacy and safety for the treatment of moderate to severe Crohn's disease and ulcerative colitis were demonstrated by phase III GEMINI studies (GEMINI 1 trial: Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis; GEMINI 2 trial: Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease). Post hoc analyses of the GEMINI studies further showed the potential benefit of vedolizumab for treating various extraintestinal manifestations, including arthralgias, pyoderma gangrenosum, erythema nodosum, and uveitis. However, findings lacked statistical significance highlighting the need for more clinical data describing vedolizumab's effects on extraintestinal manifestations. There are currently few case reports describing the effect of vedolizumab on pyoderma gangrenosum specifically. We report a Crohn's disease patient whose severe pyoderma gangrenosum of her legs, abdomen, and face have been inactive since starting vedolizumab.
- 8 January 2021
- Published by Springer Nature in Cureus
- Vol. 13 (1)
Open AccessVedolizumab (Entyvio®) for the Treatment of Pyoderma Gangrenosum in a Crohn's Disease Patient
Vedolizumab is a humanized monoclonal integrin blacker with gut selective effects on lymphocyte trafficking. Its efficacy and safety for the treatment of moderate to severe Crohn's disease and ulcerative colitis were demonstrated by phase III GEMINI studies (GEMINI 1 trial: Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis; GEMINI 2 trial: Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease). Post hoc analyses of the GEMINI studies further showed the potential benefit of vedolizumab for treating various extraintestinal manifestations, including arthralgias, pyoderma gangrenosum, erythema nodosum, and uveitis. However, findings lacked statistical significance highlighting the need for more clinical data describing vedolizumab's effects on extraintestinal manifestations. There are currently few case reports describing the effect of vedolizumab on pyoderma gangrenosum specifically. We report a Crohn's disease patient whose severe pyoderma gangrenosum of her legs, abdomen, and face have been inactive since starting vedolizumab.
- Open Access
- 1 January 2021
- Published by SAGE Publications in Journal of Investigative Medicine High Impact Case Reports
- Vol. 9
Giardia lamblia Diagnosed Incidentally by Duodenal Biopsy
Giardia lamblia (also referred to as Giardia intestinalis and Giardia duodenalis) is the most common intestinal parasite in the world, affecting approximately 200 million people annually. Symptoms of Giardia include foul-smelling diarrhea, abdominal cramping, bloating, gas, and nausea. Although usually self-limiting, Giardia can progress to dehydration, malnutrition, and failure to thrive, especially in immunocompromised individuals. Early diagnosis and treatment is imperative to prevent and control infection of Giardia. Infectious Disease Society of America diagnostic guidelines recommend obtaining stool studies to diagnose Giardia; when stool studies are negative but suspicion remains high, duodenal aspirate microscopy is the only alternative diagnostic strategy suggested. We report a patient diagnosed incidentally with Giardia from a duodenal biopsy specimen obtained during a workup for a gastrointestinal bleed. There are limited cases of Giardia diagnosed by duodenal biopsy reported in the literature. We review studies that suggest duodenal biopsy can be a very sensitive strategy for the diagnosis of Giardia.
- 1 January 2021
- Published by SAGE Publications in Journal of Investigative Medicine High Impact Case Reports
- Vol. 9
Open AccessGiardia lamblia Diagnosed Incidentally by Duodenal Biopsy
Giardia lamblia (also referred to as Giardia intestinalis and Giardia duodenalis) is the most common intestinal parasite in the world, affecting approximately 200 million people annually. Symptoms of Giardia include foul-smelling diarrhea, abdominal cramping, bloating, gas, and nausea. Although usually self-limiting, Giardia can progress to dehydration, malnutrition, and failure to thrive, especially in immunocompromised individuals. Early diagnosis and treatment is imperative to prevent and control infection of Giardia. Infectious Disease Society of America diagnostic guidelines recommend obtaining stool studies to diagnose Giardia; when stool studies are negative but suspicion remains high, duodenal aspirate microscopy is the only alternative diagnostic strategy suggested. We report a patient diagnosed incidentally with Giardia from a duodenal biopsy specimen obtained during a workup for a gastrointestinal bleed. There are limited cases of Giardia diagnosed by duodenal biopsy reported in the literature. We review studies that suggest duodenal biopsy can be a very sensitive strategy for the diagnosis of Giardia.
- Open Access
- 3 December 2020
- Published by Springer Nature in Cureus
- Vol. 12 (12)
Metastatic Melanoma Presenting as a Gastric Mass
Melanoma is the most deadly form of skin cancer. While the jejunum, ileum, colon, and rectum are common gastrointestinal sites of metastasis, metastatic melanoma to the stomach is rare and usually not discovered until late in the disease. We report a patient who presented with weight loss and hematemesis; on esophagogastroduodenoscopy, a gastric mass was found, and pathology was consistent with melanoma.
- 3 December 2020
- Published by Springer Nature in Cureus
- Vol. 12 (12)
Open AccessMetastatic Melanoma Presenting as a Gastric Mass
Melanoma is the most deadly form of skin cancer. While the jejunum, ileum, colon, and rectum are common gastrointestinal sites of metastasis, metastatic melanoma to the stomach is rare and usually not discovered until late in the disease. We report a patient who presented with weight loss and hematemesis; on esophagogastroduodenoscopy, a gastric mass was found, and pathology was consistent with melanoma.
- Open Access
- 1 August 2020
- Published by Springer Nature in Cureus
- Vol. 12 (8) , e9508
Hemopericardium in a Sirolimus-Treated Renal Transplant Patient
Sirolimus is an immunosuppressant frequently prescribed to prevent graft-vs-host disease in renal transplant patients. Pericardial effusion is recognized as a rare and potentially lethal side effect of this medication. Hemopericardium, specifically, is an even rarer complication that has yet to be reported in the literature. We report the first case of sirolimus-induced hemopericardium in a renal transplant patient.
- 1 August 2020
- Published by Springer Nature in Cureus
- Vol. 12 (8) , e9508
Open AccessHemopericardium in a Sirolimus-Treated Renal Transplant Patient
Sirolimus is an immunosuppressant frequently prescribed to prevent graft-vs-host disease in renal transplant patients. Pericardial effusion is recognized as a rare and potentially lethal side effect of this medication. Hemopericardium, specifically, is an even rarer complication that has yet to be reported in the literature. We report the first case of sirolimus-induced hemopericardium in a renal transplant patient.